Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Consistent rotation prevents lipodystrophy (changes in the subcutaneous fat tissue) and reduces the likelihood of localized irritation
Reconstitution Most peptides are available as lyophilized powders and must be reconstituted with a sterile solvent to be injected
Pain, swelling or itching can occur at the injection site
Standard maintenance protocol After the initial adaptation phase, most researchers settle into a maintenance protocol
AOD-9604 Adolescent (12 to 17) Dosing: What Clinicians and Parents Need to Know At a glance Regulatory status / No FDA approval for any indication or age group Typical research dose in adults / 250 to 500 mcg subcutaneous once daily (not validated in adolescents) Adolescent trial evidence / Zero published RCTs in the 12, 17 age group Key safety concern / Potential interference with growth-plate biology and pubertal GH axis Compounding status / Available only through 503A compounding pharmacies under prescriber order Primary preclinical evidence / Heffernan et al
US$ 21.21
US$ 24.53
US$ 25.47
